Pennant Group earnings release, May 6, 2026

Pennant Group, Inc. (PNTG) · Form 8-K, Item 2.02 · Filed · SEC filing

Pennant Reports First Quarter 2026 Results

Conference Call and Webcast scheduled for tomorrow, May 7, 2026 at 10:00 am MT

EAGLE, Idaho – May 6, 2026 (GLOBE NEWSWIRE) - The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the

Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results, reporting GAAP diluted earnings per share of $0.24 for the first quarter of 2026. Pennant also reported adjusted diluted earnings per share of $0.32 for the quarter

(1).

First Quarter Highlights

▪ Total revenue for the first quarter was $285.4 million, an increase of $75.5 million or 36.0% over the prior year quarter;

▪ Net income for the first quarter was $8.5 million, a increase of $0.7 million or 9.6% over the prior year quarter;

▪ Adjusted net income for the first quarter was $11.5 million, an increase of $1.9 million or 19.8% over the prior year quarter;

▪ Consolidated Adjusted EBITDAR for the first quarter was $34.7 million, an increase of $6.7 million or 23.9% over the prior year quarter;

▪ Consolidated Adjusted EBITDA for the first quarter was $21.7 million, an increase of $5.3 million or 32.6% over the prior year quarter;

▪ Consolidated Adjusted EBITDA prior to NCI for the first quarter was $23.5 million, an increase of $6.4 million or 37.2% over the prior year quarter;

▪ Home Health and Hospice Services segment revenue for the first quarter was $229.1 million, an increase of $69.2 million or 43.3% over the prior year quarter;

▪ Home Health and Hospice Services segment adjusted EBITDAR from operations for the first quarter was $36.8 million, an increase of $9.5 million or 34.9% over the prior year quarter; and segment adjusted EBITDA from operations for the first quarter was $33.6 million, an increase of $8.5 million or 33.7% over the prior year quarter;

▪ Total home health admissions for the first quarter were 30,721, an increase of 11,843 or 62.7% over the prior year quarter; total Medicare home health admissions for the first quarter were 13,303, an increase of 5,704 or 75.1% over the prior year quarter;

▪ Hospice average daily census for the first quarter was 5,199, an increase of 1,405 or 37.0% compared to the prior year quarter;¹

▪ Senior Living Services segment revenue for the first quarter was $56.3 million, an increase of $6.3 million or 12.6% over the prior year quarter; average occupancy for the first quarter was 78.6%, an increase of 10 basis points over the prior year quarter, and average monthly revenue per occupied room for the first quarter was $5,388, an increase of $195 or 3.8% over the prior year quarter;

▪ Senior Living segment adjusted EBITDAR from operations for the first quarter was $16.3 million, an increase of $1.8 million or 12.6% over the prior year quarter; and segment adjusted EBITDA from operations for the first quarter was $6.4 million, an increase of $1.5 million or 30.6% over the prior year quarter.

Operating Results

“Pennant is off to a strong start in 2026,” said Brent Guerisoli, the Company’s Chief Executive Officer. “After a year of dramatic expansion, we are driving operational excellence across both segments, including at our newly-acquired operations in the southeast, even as we complete their integration. That process is unfolding in line with our expectations, and we now have two of five waves of operations fully transitioned, leaders in place across the acquired agencies, and a total census above acquisition levels. When paired with the momentum in our mature businesses, we have the ingredients for a successful year.”

“Our mature operations continue to grow and deliver compelling results,” said John Gochnour, the Company’s Chief Operating Officer. “We have maintained rigor across our operations, where we are pushing for operational excellence at every level. Despite the heavy demands of integrating over 50 operations in the southeast and the headwinds of a 1.3% home health reimbursement cut, our same store margins improved, we saw strong year over year organic census and occupancy growth, and clinical outcomes continued to excel. As we continue to transition new operations and incrementally reduce duplicative expenses, we will unlock additional latent potential across our operations and drive margins toward our long term targets.”

A discussion of the Company’s use of Non-GAAP financial measures is set forth below. Reconciliations of net income to EBITDA, adjusted EBITDAR, adjusted EBITDA, and adjusted EBITDA prior to NCI, as well as a reconciliation of GAAP earnings per share, net income to adjusted net earnings per share and adjusted net income, appear in the financial data portion of this release. More complete information is contained in the Company’s Form 10-Q for the three months ended March 31, 2026, which will be filed with the SEC and will be available to be viewed on the Company’s website at www.pennantgroup.com.

Conference Call

A live webcast will be held tomorrow, May 7, 2026 at 10:00 a.m. Mountain time (12:00 p.m. Eastern time) to discuss Pennant’s first quarter 2026 financial results. To listen to the webcast, or to view any financial or statistical information required by SEC Regulation G, please visit the Investors Relations section of Pennant’s website at https://investor.pennantgroup.com. The webcast will be recorded and will be available for replay via the website.

About Pennant... (truncated)terms "we," "us," "its" and similar verbiage, are not meant to imply that The Pennant Group, Inc. has direct operating assets, employees or revenue, or that any of the home health and hospice² businesses, senior living communities or the Service Center are operated by the same entity. More information about Pennant is available at www.pennantgroup.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Financial statements

Income Statement

Three Months Ended March 31, — (unaudited, in thousands, except for per-share amounts)

Three Months Ended March 31, – 20262025
Revenue285,364209,842
Expense:Cost of services232,662168,745
Expense:Rent—cost of services13,09811,715
Expense:General and administrative expense19,68714,840
Expense:Depreciation and amortization2,6161,892
Expense:Total expenses268,063197,192
Expense:Income from operations17,30112,650
Other expense, net:Other expense-146-69
Other expense, net:Interest expense, net-3,068-1,205
Other expense, net:Other expense, net-3,214-1,274
Other expense, net:Income before provision for income taxes14,08711,376
Other expense, net:Provision for income taxes3,7942,854
Other expense, net:Net income10,2938,522
Other expense, net:Less: Net income attributable to noncontrolling interest1,774747
Other expense, net:Net income attributable to The Pennant Group, Inc.8,5197,775
Earnings per share:Basic0.250.23
Earnings per share:Diluted0.240.22
Weighted average common shares outstanding:Basic34,72634,471
Weighted average common shares outstanding:Diluted35,75735,202

Income Statement

Three Months Ended March 31, — The following table sets forth our total revenue by segment and as a percentage of total revenue for the periods indicated:

Three Months Ended March 31, – 2026 – Revenue DollarsThree Months Ended March 31, – 2026 – Revenue PercentageThree Months Ended March 31, – 2025 – Revenue DollarsThree Months Ended March 31, – 2025 – Revenue Percentage
Home health and hospice servicesHome health115,41640.474,11835.3
Home health and hospice servicesHospice99,15934.770,58633.6
Home health and hospice servicesHome care and other(a)14,5145.215,1667.2
Home health and hospice servicesTotal home health and hospice services229,08980.3159,87076.1
Home health and hospice servicesSenior living services56,27519.749,97223.9
Home health and hospice servicesTotal revenue285,364100209,842100

Income Statement

Three Months Ended March 31, — The following table presents our total revenue by payor source as a percentage of total revenue for the periods indicated:

Three Months Ended March 31, – 2026 – Revenue DollarsThree Months Ended March 31, – 2026 – Revenue Percentage2025 – Revenue DollarsRevenue Percentage
Revenue:Medicare144,85850.8101,12548.2
Revenue:Medicaid37,32113.127,33813
Revenue:Subtotal182,17963.9128,46361.2
Revenue:Managed care45,7271630,71414.6
Revenue:Private and other(a)57,45820.150,66524.2
Revenue:Total revenue285,364100209,842100

Income Statement

Three Months Ended March 31, — The following table reconciles net income to Non-GAAP net income for the periods presented:

Three Months Ended March 31, – 20262025
Net income attributable to The Pennant Group, Inc.8,5197,775
Non-GAAP adjustmentsCosts at start-up operations(a)53993
Non-GAAP adjustmentsShare-based compensation expense(b)2,5892,167
Non-GAAP adjustmentsAcquisition related costs(c)354272
Non-GAAP adjustmentsActivities associated with transitioning operations(d)75
Non-GAAP adjustmentsTransition services costs(e)407
Non-GAAP adjustmentsUnusual, non-recurring or redundant charges(f)51
Non-GAAP adjustmentsProvision for income taxes on Non-GAAP adjustments(g)-880-809
Non-GAAP adjustmentsNon-GAAP net income11,5289,624
Dilutive Earnings Per Share As ReportedNet Income0.240.22
Dilutive Earnings Per Share As ReportedAverage number of shares outstanding35,75735,202
Adjusted Diluted Earnings Per ShareNet Income0.320.27
Adjusted Diluted Earnings Per ShareAverage number of shares outstanding35,75735,202

Income Statement

Three Months Ended March 31,

Three Months Ended March 31, – 20262025
Consolidated net income10,2938,522
Less: Net income attributable to noncontrolling interest1,774747
Add: Provision for income taxes3,7942,854
Net interest expense3,0681,205
Depreciation and amortization2,6161,892
Consolidated EBITDA17,99713,726
Adjustments to Consolidated EBITDAAdd: Start-up operations(a)29578
Adjustments to Consolidated EBITDAShare-based compensation expense(b)2,5892,167
Adjustments to Consolidated EBITDAAcquisition related costs(c)354272
Adjustments to Consolidated EBITDAActivities associated with transitioning operations(d)20
Adjustments to Consolidated EBITDATransition services costs(e)407
Adjustments to Consolidated EBITDAOther unusual, non-recurring, or redundant charges(f)51
Adjustments to Consolidated EBITDARent related to items (a) and (d) above6859
Adjustments to Consolidated EBITDAConsolidated Adjusted EBITDA21,71016,373
Adjustments to Consolidated EBITDARent—cost of services13,09811,715
Adjustments to Consolidated EBITDARent related to items (a) and (d) above-68-59
Adjustments to Consolidated EBITDAAdjusted rent—cost of services13,03011,656
Adjustments to Consolidated EBITDAConsolidated Adjusted EBITDAR(g)34,740

Income Statement

Three Months Ended March 31,

Three Months Ended March 31, – 20262025
Net income attributable to The Pennant Group, Inc.8,5197,775
Add: Provision for income taxes3,7942,854
Net interest expense3,0681,205
Depreciation and amortization2,6161,892
Consolidated EBITDA17,99713,726
Adjustments to Consolidated EBITDAAdd: Start-up operations(a)29578
Adjustments to Consolidated EBITDAShare-based compensation expense(b)2,5892,167

Income Statement

Three Months Ended March 31, — The table below provides a reconciliation of Segment Adjusted EBITDAR from Operations above to income from operations:

Three Months Ended March 31, – 20262025
Segment Adjusted EBITDAR from Operations(a)53,06541,723
Less: Unallocated corporate expenses18,32513,694
Less: Depreciation and amortization2,6161,892
Rent—cost of services13,09811,715
Other income-146-69
Adjustments to Segment EBITDAR from Operations:Less: Start-up operations(b)29578
Adjustments to Segment EBITDAR from Operations:Share-based compensation expense(c)2,5892,167
Adjustments to Segment EBITDAR from Operations:Acquisition related costs(d)354272
Adjustments to Segment EBITDAR from Operations:Activities associated with transitioning operations(e)20
Adjustments to Segment EBITDAR from Operations:Transition services costs(f)407
Adjustments to Segment EBITDAR from Operations:Other unusual, non-recurring, or redundant charges(g)51
Adjustments to Segment EBITDAR from Operations:Add: Net income attributable to noncontrolling interest1,774747
Adjustments to Segment EBITDAR from Operations:Income from operations17,30112,650

Balance Sheet

March 31, 2026 — (in thousands, except par value)

March 31, 2026December 31, 2025
Current assets:Cash4,91217,024
Current assets:Accounts receivable—less allowance for doubtful accounts of $701 and $681, at March 31, 2026 and December 31, 2025 respectively122,820123,109
Current assets:Prepaid expenses and other current assets25,09227,273
Current assets:Total current assets152,824167,406
Current assets:Property and equipment, net63,97360,984
Current assets:Operating lease right-of-use assets273,179275,947
Current assets:Deferred tax assets, net54478
Current assets:Restricted and other assets29,76626,676
Current assets:Goodwill237,246237,246
Current assets:Other indefinite-lived intangibles199,442199,442
Current assets:Total assets956,484968,179
Current liabilities:Accounts payable22,79825,171
Current liabilities:Accrued wages and related liabilities40,30365,229
Current liabilities:Operating lease liabilities—current25,55725,013
Current liabilities:Current maturities of long-term debt5,0005,000
Current liabilities:Other accrued liabilities34,91726,851
Current liabilities:Total current liabilities128,575147,264
Current liabilities:Long-term operating lease liabilities—less current portion251,258254,311
Current liabilities:Deferred tax liabilities, net1,317150
Current liabilities:Other long-term liabilities21,23023,365
Current liabilities:Long-term debt164,668168,837
Current liabilities:Total liabilities567,048593,927
Equity:Common stock, $0.001 par value; 100,000 shares authorized; 34,992 and 34,746 shares issued and outstanding at March 31, 2026, respectively; and 34,878 and 34,626 shares issued and outstanding at December 31, 2025, respectively3535
Equity:Additional paid-in capital250,724245,833
Equity:Retained earnings95,31986,800
Equity:Treasury stock, at cost, 3 shares at March 31, 2026 and December 31, 2025-65-65
Equity:Total The Pennant Group, Inc. stockholders’ equity346,013332,603
Equity:Noncontrolling interest43,42341,649
Equity:Total equity389,436374,252
Equity:Total liabilities and equity956,484968,179

Cash Flow

Three Months Ended March 31, — The following table presents selected data from our condensed consolidated statements of cash flows for the periods presented:

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
Net cash used in operating activities-3,405-21,229
Net cash used in investing activities-5,380-50,301
Net cash (used in) provided by financing activities-3,32752,505
Net decrease in cash-12,112-19,025
Cash beginning of period17,02424,246
Cash end of period4,9125,221
Full release

This press release contains, and the related conference call and webcast will include, forward-looking statements that are based on management’s current expectations, assumptions and beliefs about its business, financial performance, operating results, the industry in which it operates and other future events. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. These forward-looking statements include, but are not limited to, statements regarding growth prospects, future operating and financial performance, and acquisition activities. They are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to materially and adversely differ from those expressed in any forward-looking statement.

These risks and uncertainties relate to the company’s business, its industry and its common stock and include: reduced prices and reimbursement rates for its services; its ability to acquire, develop, manage or improve operations, its ability to manage its increasing borrowing costs as it incurs additional indebtedness to fund the acquisition and development of operations; its ability to access capital on a cost-effective basis to continue to successfully implement its growth strategy; its operating margins and profitability could suffer if it is unable to grow and manage effectively its increasing number of operations; competition from other companies in the acquisition, development and operation of facilities; its ability to defend claims and lawsuits, including professional liability claims alleging that our services resulted in personal injury, and other regulatory-related claims; and the application of existing or proposed government regulations, or the adoption of new laws and regulations, that could limit its business operations, require it to incur significant expenditures or limit its ability to relocate its operations if necessary. Readers should not place undue reliance on any forward-looking statements and are encouraged to review the company’s periodic filings with the Securities and Exchange Commission, including its Form 10-Q and/or 10-K, for a more complete discussion of the risks and other factors that could affect Pennant’s business, prospects and any forward-looking statements. Except as required by the federal securities laws, Pennant does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.

Contact Information

Investor Relations

The Pennant Group, Inc.

(208) 401-1400 ir@pennantgroup.com

SOURCE: The Pennant Group, Inc.³

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Pennant Group earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.